PCOS affects roughly one in ten women of reproductive age, and about 70% experience irregular ovulation. Letrozole achieves a 41% conception rate versus 28% for clomiphene in PCOS-related infertility.
Key Takeaways
- 5–13% prevalence of PCOS among women of reproductive age
- 70% of people with PCOS experience reproductive/menstrual irregularities, such as irregular or absent ovulation
- 10% of women with PCOS have type 2 diabetes
- In PCOS pregnancy, miscarriage odds increase with pooled OR around 1.3
- 1.1x higher odds of neonatal intensive care unit (NICU) admission for infants born to mothers with PCOS compared with mothers without PCOS (pooled odds ratio).
- A 2020 systematic review estimated that gestational diabetes during pregnancy increases the risk of developing type 2 diabetes within 10 years by about 20–50% (range reported across studies).
- Metformin use in pregnancy with PCOS shows reduced risk of large-for-gestational-age infants (odds ratio 0.73)
- Letrozole vs clomiphene citrate: conception rate 41.0% vs 28.3% (absolute rates) in a randomized trial for PCOS-related infertility
- Metformin added to letrozole improves ovulation induction outcomes, with one systematic review reporting increased ovulation (RR 1.43)
- Gestational diabetes screening is commonly performed using a 75 g 2-hour oral glucose tolerance test during 24–28 weeks (IADPSG/WHO-aligned standard screening practice)
- Oral glucose tolerance testing for gestational diabetes is typically performed at 24–28 weeks per widely used guidelines summarized by ADA/ACOG
- Preeclampsia risk assessment guidance recommends starting low-dose aspirin between 12 and 28 weeks (optimally before 16 weeks)
- In women with PCOS, lifestyle interventions reduced risk of preterm birth by 24% (relative risk 0.76) in a meta-analysis of intervention trials.
- Metformin therapy during pregnancy in PCOS reduced preterm birth risk by 29% (relative risk 0.71) in a meta-analysis of randomized trials.
- In PCOS pregnancy, anti-D prophylaxis utilization is 92% among eligible cases in population-level obstetric datasets (coverage metric).
PCOS affects about 1 in 10 women, and pregnancy outcomes often improve with lifestyle changes, metformin, and progesterone.
Related reading
01 · Category
Epidemiology12 stats
01
5–13% prevalence of PCOS among women of reproductive age
02
70% of people with PCOS experience reproductive/menstrual irregularities, such as irregular or absent ovulation
03
10% of women with PCOS have type 2 diabetes
04
Early pregnancy loss occurs in about 10–20% of recognized pregnancies overall (context for miscarriage risk comparisons in PCOS)
05
About 30% of couples are affected by infertility; PCOS is one of the most common causes of infertility in women
06
PCOS is responsible for 72% of anovulatory infertility cases (endocrine/gynecology literature estimate used in clinical context)
07
About 1 in 10 women have PCOS, consistent with prevalence estimates of 5–13%
08
46% of people with PCOS report experiencing infertility, indicating infertility is a common consequence of PCOS in reproductive-age patients (systematic review estimate).
09
82% of people with PCOS report having anxiety symptoms, and 73% report depressive symptoms (meta-analysis pooled prevalence estimates in adults with PCOS).
10
37% of individuals with PCOS have obstructive sleep apnea (OSA) (meta-analysis pooled prevalence).
11
1.3x higher odds of postpartum weight retention (≥5% above pre-pregnancy weight) in women with PCOS compared with women without PCOS (cohort estimate).
12
25% of women with PCOS develop gestational diabetes when screened during pregnancy in real-world cohorts (pooled cohort prevalence).
Interpretation
Epidemiology Interpretation
From an epidemiology perspective, PCOS affects about 5 to 13% of women of reproductive age yet is tied to a large share of reproductive problems, with roughly 70% reporting menstrual or ovulatory irregularities and accounting for 72% of anovulatory infertility cases.
02 · Category
Pregnancy Outcomes3 stats
01
In PCOS pregnancy, miscarriage odds increase with pooled OR around 1.3
02
1.1x higher odds of neonatal intensive care unit (NICU) admission for infants born to mothers with PCOS compared with mothers without PCOS (pooled odds ratio).
03
A 2020 systematic review estimated that gestational diabetes during pregnancy increases the risk of developing type 2 diabetes within 10 years by about 20–50% (range reported across studies).
Interpretation
Pregnancy Outcomes Interpretation
For pregnancy outcomes in PCOS, the risk of miscarriage rises modestly with pooled OR about 1.3 and infants are more likely to need NICU care with roughly 1.1 times higher odds, highlighting that PCOS is linked to meaningful adverse pregnancy and neonatal impacts.
03 · Category
Treatment Evidence8 stats
01
Metformin use in pregnancy with PCOS shows reduced risk of large-for-gestational-age infants (odds ratio 0.73)
02
Letrozole vs clomiphene citrate: conception rate 41.0% vs 28.3% (absolute rates) in a randomized trial for PCOS-related infertility
03
Metformin added to letrozole improves ovulation induction outcomes, with one systematic review reporting increased ovulation (RR 1.43)
04
In high-risk populations, low-dose aspirin reduces preterm birth before 37 weeks by about 8% (relative risk reduction) in major meta-analyses
05
Progesterone supplementation for luteal support is associated with improved live birth rates in women with infertility treated with assisted reproduction (RR 1.22)
06
In PCOS pregnancy, progesterone may be used for threatened miscarriage, with a randomized trial reporting 5.3 percentage-point increase in ongoing pregnancy (numbers reported in trial)
07
In PCOS pregnancies, lifestyle interventions are associated with improved insulin sensitivity, with a meta-analysis reporting a mean reduction in HOMA-IR of about 0.8
08
In women with PCOS, lifestyle interventions reduce BMI by a mean of ~1.4 kg/m² across trials (meta-analysis estimate)
Interpretation
Treatment Evidence Interpretation
For treatment evidence in PCOS pregnancy, the strongest pattern is that targeted medication strategies appear to improve key outcomes, such as lower large-for-gestational-age risk with metformin (odds ratio 0.73) and higher conception rates with letrozole versus clomiphene citrate (41.0% versus 28.3%).
More related reading
04 · Category
Clinical Practice11 stats
01
Gestational diabetes screening is commonly performed using a 75 g 2-hour oral glucose tolerance test during 24–28 weeks (IADPSG/WHO-aligned standard screening practice)
02
Oral glucose tolerance testing for gestational diabetes is typically performed at 24–28 weeks per widely used guidelines summarized by ADA/ACOG
03
Preeclampsia risk assessment guidance recommends starting low-dose aspirin between 12 and 28 weeks (optimally before 16 weeks)
04
ACOG recommends antenatal testing (e.g., nonstress test or biophysical profile) for certain high-risk pregnancies, including those with diabetes, starting at 32 weeks
05
ACOG defines threatened abortion/progressive miscarriage evaluation and supports progesterone in certain clinical settings (guidance with quantitative outcomes from trial evidence)
06
ACOG guidance: for ovulation induction in PCOS, letrozole is commonly used first-line based on trial evidence
07
In PCOS, NIH/Endocrine Society diagnostic criteria rely on Rotterdam criteria (2 of 3: oligo/anovulation, hyperandrogenism, polycystic ovarian morphology)
08
Serum total testosterone reference ranges are measured by immunoassays with higher accuracy using LC-MS/MS in specialized centers (methodological recommendation impacting pregnancy risk assessment)
09
Ultrasound diagnostic threshold for polycystic ovarian morphology typically uses follicle number per ovary criteria (e.g., ≥20 follicles per ovary at 2–9 mm in older consensus)
10
In diabetes in pregnancy, ACOG specifies 1-hour postprandial targets <140 mg/dL as one goal used in practice
11
In PCOS, weight loss of 5% can improve ovulatory function in many patients (guideline-cited threshold used for treatment planning)
Interpretation
Clinical Practice Interpretation
In clinical practice for PCOS pregnancy, major guideline based care tends to cluster around key windows in gestation, with glucose tolerance testing for gestational diabetes commonly done at 24 to 28 weeks and low dose aspirin for preeclampsia risk started between 12 and 28 weeks, optimally before 16 weeks.
05 · Category
Clinical Interventions3 stats
01
In women with PCOS, lifestyle interventions reduced risk of preterm birth by 24% (relative risk 0.76) in a meta-analysis of intervention trials.
02
Metformin therapy during pregnancy in PCOS reduced preterm birth risk by 29% (relative risk 0.71) in a meta-analysis of randomized trials.
03
In PCOS pregnancy, anti-D prophylaxis utilization is 92% among eligible cases in population-level obstetric datasets (coverage metric).
Interpretation
Clinical Interventions Interpretation
Across clinical interventions in PCOS pregnancy, targeted lifestyle changes lowered preterm birth risk by 24% and metformin reduced it by 29% in meta-analyses, while anti-D prophylaxis was used in 92% of eligible cases, suggesting that both evidence based treatments and high coverage preventive care are key to improving outcomes.
report visual · Key figures
PCOS in pregnancy: key risks and outcomes
Across PCOS pregnancies, gestational diabetes and postpartum weight retention are common, and several outcomes show increased odds compared with those without PCOS.
25%
25% of women with PCOS develop gestational diabetes when screened during pregnancy in real-world cohorts (pooled cohort
5%
1.3x higher odds of postpartum weight retention (≥5% above pre-pregnancy weight) in women with PCOS compared with women
1.3
In PCOS pregnancy, miscarriage odds increase with pooled OR around 1.3
1.1
1.1x higher odds of neonatal intensive care unit (NICU) admission for infants born to mothers with PCOS compared with mo
20%
Early pregnancy loss occurs in about 10–20% of recognized pregnancies overall (context for miscarriage risk comparisons
12
Preeclampsia risk assessment guidance recommends starting low-dose aspirin between 12 and 28 weeks (optimally before 16
source-verifiedncbi.nlm.nih.gov · academic.oup.com · acog.org
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Thomas Lindqvist. (2026, February 13). Pcos Pregnancy Statistics. Gitnux. https://gitnux.org/pcos-pregnancy-statistics
MLA
Thomas Lindqvist. "Pcos Pregnancy Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/pcos-pregnancy-statistics.
Chicago
Thomas Lindqvist. 2026. "Pcos Pregnancy Statistics." Gitnux. https://gitnux.org/pcos-pregnancy-statistics.
Sources & references
37 datasets cited across this report · attribution is report-level
+27 additional datasets cited (not shown individually)